|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||||
|
||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s59405DE8-37F2-11EF-94B8-4A8685CE164B&I=39IZM&T=&OP=Display&O=html&O1=12663096&O2=4100000007761950&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DReal-world%2520evidence%2520on%2520siponimod%2520treatment%2520in%2520patients%2520with%2520secondary%2520progressive%2520multiple%2520sclerosis%26rft.au%3DAlice%2520Willison%26rft.au%3DLeoni%2520Rolfes%26rft.au%3DLiesa%2520Regner-Nelke%26rft.au%3DMarc%2520Pawlitzki%26rft.date%3D2022-11-07%26rft.eissn%3D2524-3489%26rft.epage%3D11%26rft.externalDBID%3DDOA%26rft.externalDocID%3Doai_doaj_org_article_ae53dbd9ba474b64ab5dcb39c73e00f6%26rft.genre%3Darticle%26rft.issue%3D1%26rft.jtitle%3DNeurological%2520research%2520and%2520practice%26rft.pub%3DBMC%26rft.spage%3D1%26rft.volume%3D4%26rft_id%3Dinfo%253Adoi%252F10.1186%252Fs42466-022-00219-3%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-UNPAYWALL-getFullTxt-object,2-PUBMED_CENTRAL_JOURNALS-getFullTxt-object,3-DOAJ_DIRECTORY_OPEN_ACCESS_JOURNALS-getFullTxt-object,4-EZB-FREE-00999_FREELY_AVAILABLE_EZB_JOURNALS-getFullTxt-object,5-PROQUEST_CENTRAL-getFullTxt-object,6-PUBMED_CENTRAL_OPEN_ACCESS_FREE-getFullTxt-object,7-COBIB_SI_LCL-getHolding-object,8-DOI-getDOI-object,9-REFWORKS_EXPORT_TOOL-getReference-object,10-GOOGLE_SCHOLAR_FREE-getWebSearch-object,11-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.344709&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:12663096-s59405DE8-37F2-11EF-94B8-4A8685CE164B" timestamp="2024-07-01T23:39:09Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:4100000007761950</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis</jnl:atitle>
<jnl:jtitle>Neurological Research and Practice</jnl:jtitle>
<jnl:date>2022-12-00</jnl:date>
<jnl:spage>1</jnl:spage>
<jnl:epage>11</jnl:epage>
<jnl:volume>4</jnl:volume>
<jnl:issue>1</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>2524-3489</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:bc95322dd15157a47f13e71b4752cdd324e373fa</ctx:identifier>
<ctx:identifier>urn:UUID:s59405DE8-37F2-11EF-94B8-4A8685CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)